Sharron Gargosky

3.8k total citations
67 papers, 2.9k citations indexed

About

Sharron Gargosky is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Sharron Gargosky has authored 67 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Molecular Biology and 13 papers in Genetics. Recurrent topics in Sharron Gargosky's work include Growth Hormone and Insulin-like Growth Factors (47 papers), Metabolism, Diabetes, and Cancer (11 papers) and Lipid metabolism and disorders (10 papers). Sharron Gargosky is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (47 papers), Metabolism, Diabetes, and Cancer (11 papers) and Lipid metabolism and disorders (10 papers). Sharron Gargosky collaborates with scholars based in United States, Australia and Sweden. Sharron Gargosky's co-authors include Ron G. Rosenfeld, Linda C. Giudice, Youngman Oh, Tomoko Matsumoto, B A Dsupin, Raymond L. Hintz, Kristin F. Wilson, Diane M. Simpson, R G Rosenfeld and Jaime Guevara‐Aguirre and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Sharron Gargosky

66 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharron Gargosky United States 30 1.8k 917 629 534 360 67 2.9k
Anne Bachelot France 36 1.6k 0.9× 1.5k 1.6× 322 0.5× 974 1.8× 239 0.7× 132 4.0k
Paul Hossenlopp France 23 2.5k 1.3× 1.7k 1.9× 253 0.4× 616 1.2× 377 1.0× 29 3.4k
E. R. Froesch Switzerland 20 2.2k 1.2× 1.5k 1.6× 211 0.3× 640 1.2× 268 0.7× 31 3.3k
Andrew Dauber United States 31 962 0.5× 1.3k 1.4× 354 0.6× 1.3k 2.5× 172 0.5× 109 2.8k
Thanh Vu United States 38 390 0.2× 2.6k 2.9× 693 1.1× 1.5k 2.8× 43 0.1× 65 3.9k
Ana‐Maria Bamberger Germany 39 597 0.3× 1.3k 1.5× 231 0.4× 745 1.4× 34 0.1× 87 3.9k
Martin Jansen Austria 22 890 0.5× 722 0.8× 115 0.2× 410 0.8× 113 0.3× 39 1.9k
Anthony N. Corps United Kingdom 29 235 0.1× 902 1.0× 185 0.3× 236 0.4× 89 0.2× 47 2.3k
Gunnar Rannevik Sweden 26 755 0.4× 493 0.5× 132 0.2× 522 1.0× 35 0.1× 62 2.7k
Sawako Minami Japan 19 211 0.1× 772 0.8× 168 0.3× 188 0.4× 88 0.2× 56 2.0k

Countries citing papers authored by Sharron Gargosky

Since Specialization
Citations

This map shows the geographic impact of Sharron Gargosky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharron Gargosky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharron Gargosky more than expected).

Fields of papers citing papers by Sharron Gargosky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharron Gargosky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharron Gargosky. The network helps show where Sharron Gargosky may publish in the future.

Co-authorship network of co-authors of Sharron Gargosky

This figure shows the co-authorship network connecting the top 25 collaborators of Sharron Gargosky. A scholar is included among the top collaborators of Sharron Gargosky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharron Gargosky. Sharron Gargosky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhatia, Shailender, Natalie Miller, Rima M. Kulikauskas, et al.. (2019). Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma. Clinical Cancer Research. 26(3). 598–607. 70 indexed citations
2.
Apostolopoulos, Vasso, Lily Stojanovska, & Sharron Gargosky. (2015). MUC1 (CD227): a multi-tasked molecule. Cellular and Molecular Life Sciences. 72(23). 4475–4500. 97 indexed citations
3.
Mitchell, Paul, Michael Quinn, Peter Grant, et al.. (2014). A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer. Journal for ImmunoTherapy of Cancer. 2(1). 16–16. 29 indexed citations
4.
Buchholz, Malte, Jens Knauer, Jörg Lehmann, Martha A. Hass, & Sharron Gargosky. (2013). Qualification of the COSTIM assay to determine potency and use in clinical trials. Cytotherapy. 15(4). S51–S51. 1 indexed citations
5.
Gargosky, Sharron, Sheena Gupta, & Heather Maecker. (2013). Qualification of an intracellular cytokine staining (ICS) assay to evaluate mucin 1-specific T cell responses in ovarian cancer patients treated with CVAC immunotherapy. Cytotherapy. 15(4). S48–S48. 1 indexed citations
6.
McGuire, Brendan M., И. А. Зупанец, Mark E. Lowe, et al.. (2010). Pharmacology and Safety of Glycerol Phenylbutyrate in Healthy Adults and Adults With Cirrhosis. Hepatology. 51(6). 2077–2085. 57 indexed citations
7.
Gargosky, Sharron, et al.. (2001). The Role of Growth Hormone in Adaptation to Massive Small Intestinal Resection in Rats. Pediatric Research. 49(2). 189–196. 4 indexed citations
8.
Guevara‐Aguirre, Jaime, Arlan L. Rosenbloom, Oswaldo Vasconez, et al.. (1997). Two-Year Treatment of Growth Hormone (GH) Receptor Deficiency with Recombinant Insulin-Like Growth Factor I in 22 Children: Comparison of Two Dosage Levels and to GH-Treated GH Deficiency1. The Journal of Clinical Endocrinology & Metabolism. 82(2). 629–633. 101 indexed citations
9.
10.
Rosenfeld, Ron G. & Sharron Gargosky. (1996). Assays for insulin-like growth factors and their binding proteins: Practicalities and pitfalls. The Journal of Pediatrics. 128(5). S52–S57. 22 indexed citations
11.
Kelley, Kevin M., Youngman Oh, Sharron Gargosky, et al.. (1996). Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. The International Journal of Biochemistry & Cell Biology. 28(6). 619–637. 401 indexed citations
12.
Mandel, Scott, et al.. (1996). Collection of blood in heparinized tubes does not alter the molecular distribution or forms of IGFBP-3 and IGF. Endocrine. 5(1). 1–8. 9 indexed citations
13.
Matsumoto, Tomoko, Sharron Gargosky, Youngman Oh, & R G Rosenfeld. (1996). Transcriptional and post-translational regulation of insulin-like growth factor-binding protein-5 in rat articular chondrocytes. Journal of Endocrinology. 148(2). 355–369. 25 indexed citations
14.
Gargosky, Sharron, et al.. (1996). Regulation of Postjatal Intestinal Maturation by Growth Hormone: Studies in Rats with Isolated Growth Hormone Deficiency. Pediatric Research. 40(1). 88–93. 8 indexed citations
15.
Tarantal, A. F., Sharron Gargosky, D. S. Ellis, William D. O’Brien, & A.G. Hendrickx. (1995). Hematologic and growth-related effects of frequent prenatal ultrasound exposure in the long-tailed macaque (Macaca fascicularis). Ultrasound in Medicine & Biology. 21(8). 1073–1081. 17 indexed citations
16.
17.
Müller, Hermann L., Youngman Oh, Sharron Gargosky, et al.. (1994). Insulin-Like Growth Factor Binding Protein-3 Concentrations and Insulin-Like Growth Factor Binding Protein-3 Protease Activity in Sera of Patients with Malignant Solid Tumors or Leukemia. Pediatric Research. 35(6). 720–724. 25 indexed citations
18.
Gargosky, Sharron, Kirsti Näntö‐Salonen, Päivi Tapanainen, & R G Rosenfeld. (1993). Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity. Journal of Endocrinology. 136(3). 479–489. 21 indexed citations
19.
Diamond, F, Jaime Guevara‐Aguirre, Arlan L. Rosenbloom, et al.. (1993). Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.. The Journal of Clinical Endocrinology & Metabolism. 77(1). 273–280. 105 indexed citations
20.
Cohen, Pinchas, Ian Ocrant, Paul J. Fielder, et al.. (1992). Insulin-like growth factors (IGFs): Implications for aging. Psychoneuroendocrinology. 17(4). 335–342. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Bachelot Breakdown of academic impact, for papers by Paul Hossenlopp Breakdown of academic impact, for papers by E. R. Froesch Breakdown of academic impact, for papers by Andrew Dauber Breakdown of academic impact, for papers by Thanh Vu Breakdown of academic impact, for papers by Ana‐Maria Bamberger Breakdown of academic impact, for papers by Martin Jansen Breakdown of academic impact, for papers by Anthony N. Corps Breakdown of academic impact, for papers by Gunnar Rannevik Breakdown of academic impact, for papers by Sawako Minami
Rankless by CCL
2026